Polymyositis Clinical Trials Polymyositis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
Conditions:   Polymyositis;   Dermatomyositis Intervention:   Drug: KZR-616 Sponsor:   Kezar Life Sciences, Inc. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials